PPARGC1A and heart failure: With respect to these limitations, our data cannot actually prove causality of reinforced BNP/NPR-A/PGC-1α-pathway for ameliorated myopathy in heart failure, but they may contribute to the growing evidence for this mechanistic path as discussed above[14].